Phenotype
|
Conditions
|
Figures
|
hepatocyte apoptotic, abnormal
|
increased food availability, particle radiation
|
Figure 4
from Wu et al., 2020
|
hepatocyte apoptotic, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 4
from Wu et al., 2020
|
hepatocyte morphology, abnormal
|
increased food availability, particle radiation
|
Figure 5
from Wu et al., 2020
|
hepatocyte morphology, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 5
from Wu et al., 2020
|
hepatocyte apoptotic process increased occurrence, abnormal
|
increased food availability, particle radiation
|
Figure 4
from Wu et al., 2020
|
hepatocyte apoptotic process occurrence, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 4
from Wu et al., 2020
|
liver cdk1 expression amount, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver ccne1 expression amount, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver hpse expression amount, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver hsd11b1lb expression amount, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 9
from Wu et al., 2020
|
liver ccn2a expression amount, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver col1a1a expression amount, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver cdk2 expression amount, ameliorated
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver hnf4a expression increased amount, abnormal
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 9
from Wu et al., 2020
|
liver tdo2a expression increased amount, abnormal
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 9
from Wu et al., 2020
|
liver ccne1 expression increased amount, abnormal
|
increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver cdk1 expression increased amount, abnormal
|
increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver cdk2 expression increased amount, abnormal
|
increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver hpse expression increased amount, abnormal
|
increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver ddah1 expression increased amount, abnormal
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 9
from Wu et al., 2020
|
liver col1a1a expression increased amount, abnormal
|
increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver asgrl1 expression increased amount, abnormal
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 9
from Wu et al., 2020
|
liver ccn2a expression increased amount, abnormal
|
increased food availability, particle radiation
|
Figure 3
from Wu et al., 2020
|
liver hepatocellular carcinoma amount, ameliorated
|
increased food availability, particle radiation
|
Figure 5
from Wu et al., 2020
|
liver hepatocyte proliferation normal occurrence, normal
|
increased food availability, particle radiation
|
Figure 5
from Wu et al., 2020
|
liver hepatocyte proliferation normal occurrence, normal
|
chemical treatment by gavage: fucoidan, increased food availability, particle radiation
|
Figure 5
from Wu et al., 2020
|